相关实验视频

Updated: Jul 8, 2025

Semi-automatic PD-L1 Characterization and Enumeration of Circulating Tumor Cells from Non-small Cell Lung Cancer Patients by Immunofluorescence
10:29

Semi-automatic PD-L1 Characterization and Enumeration of Circulating Tumor Cells from Non-small Cell Lung Cancer Patients by Immunofluorescence

Published on: August 14, 2019

10.6K

免疫检查点抑制剂在扩展阶段小细胞肺癌的机会和挑战

Jing Zhao1,2, Xiaoli Zhuo1,2, Lei Liu1,2

  • 1The Department of Oncology Shandong Provincial Hospital Affiliated to Shandong First Medical University Jinan China.

Cancer innovation
|December 13, 2023
PubMed
概括

小细胞肺癌 (SCLC) 是一种侵袭性癌症,通常在晚期被诊断出来. 目前广泛阶段SCLC的第一线治疗将化疗与免疫疗法结合起来,为患者提供新的选择.

关键词:
免疫检查点抑制剂 免疫检查点抑制剂分子类型的分子类型.小细胞肺癌是什么?有针对性的治疗.

更多相关视频

Identifying PD-1/PD-L1 Inhibitors with Surface Plasmon Resonance Technology07:04

Identifying PD-1/PD-L1 Inhibitors with Surface Plasmon Resonance Technology

Published on: May 2, 2025

328
Patient-Derived Tumor Explants As a "Live" Preclinical Platform for Predicting Drug Resistance in Patients07:42

Patient-Derived Tumor Explants As a "Live" Preclinical Platform for Predicting Drug Resistance in Patients

Published on: February 7, 2021

5.0K

相关概念视频

Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
529